 |
|
|
| |
AASLD ( American Association for the Study of Liver Diseases) Conference
Dallas, Texas - Nov 2001 |
| |
| |
- Hepatitis C Report from AASLD: HIV/coinfection; new HCV drugs Written for NATAP by Andrew Talal, MD, Cornell-NY Hospital, GI and Hepatology Clinic - Jan 23, 2002
- NATAP REPORT OF HEPATITIS ABSTRACTS PRESENTED AT 52ND ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES Written for NATAP by Andrew Talal, MD, Cornell-Ny Hospital, NYC - Jan 07, 2002
- 40% HCV Prevalence in HIV Clinic in SF - Jan 02, 2002
- TREATMENT OF HEPATITIS C CIRRHOSIS USING PEGYLATED INTERFERON: MONEY WELL SPENT? - Jan 02, 2002
- Toxicities in HIV/HCV Coinfected Treated with Peg-Intron + RBV - Jan 02, 2002
- FIBROSIS (F) AND HISTOLOGICAL ACTIVITY INDEX (HAI) IMPROVE SPONTANEOUSLY IN UNTREATED, NONCIRRHOTIC, PERSISTENTLY VIREMIC IRISH WOMEN WITH CHRONIC HEPATITIS C. - Dec 4, 2001
- PREDICTIVE VARIABLES OF HCV-RELATED DISEASE PROGRESSION: NEGATIVE EFFECT OF OVERWEIGHT: diabetes, ALT >60, and weight can have an effect on HCV progression - Dec 4, 2001
- INFLUENCE OF STEATOSIS ON CHRONIC HEPATITIS C OUTCOME: PROSPECTIVE STUDY OF 164 PATIENTS WITH CIRRHOSIS - Dec 4, 2001
- TIMING THE ANCESTRY OF HEPATITIS C VIRUS GENOTYPE 1A STRAINS IN THE UNITED STATES: the number of mutations don't seem to be associated with disease progression - Dec 4, 2001
- IMPACT OF PREGNANCIES, ORAL CONTRACEPTION AND MENOPAUSE ON LIVER FIBROSIS PROGRESSION IN WOMEN WITH CHRONIC HEPATITIS C - Dec 3, 2001
- CLINICAL IMPLICATIONS OF A NEW TRI-PHASIC MODEL FOR HEPATITIS C VIRAL KINETICS DURING IFN-a THERAPY
- Dec 3, 2001
- SAFE AND POTENT SUPPRESSION OF HEPATITIS B VIRUS (HBV) WITH
L-DEOXYTHYMIDINE (LDT): RESULTS OF A DOSE-ESCALATION TRIAL
- Nov 30, 2001
- IMPACT OF HIV COINFECTION ON THE AGE AND THE CAUSE OF DEATH IN PATIENTS WITH HCV CIRRHOSIS - Nov 30, 2001
- EFFECT OF INTERFERON AND RIBAVIRIN ON PROGRESSION OF LIVER FIBROSIS IN PATIENTS WITH SEVERE CHRONIC HEPATITIS C. - Nov 30, 2001
- LONG-LASTING SUSTAINED VIROLOGICAL RESPONSE IN CHRONIC HEPATITIS C PATIENTS PREVIOUSLY TREATED WITH 40 KDA PEGINTERFERON ALFA-2A (PEGASYS) - Nov 30, 2001
- ENHANCED VIROLOGICAL RESPONSE TO TREATMENT WITH 40 KDA PEGINTERFERON ALFA-2A (PEGASYS) IN PATIENTS PREVIOUSLY UNRESPONSIVE TO TREATMENT WITH INTERFERON ALFA-2A - Nov 30, 2001
- Durability of Sustained Virologic response in patients with Chronic Hepatitis c after treatment With Interferon 2b Alone or in Combination with Ribavirin - Nov 29, 2001
- Impact of Pegylated Interferon alfa-2b (Peg-Intron) and Ribavirin on Progression of Liver Fibrosis in patients with Chronic Hepatitis C - Nov 28, 2001
- ACUTE HEPATITIS C: NATURAL COURSE AND RESPONSE TO ANTIVIRAL TREATMENT - Nov 27, 2001
- Quality of Life at week 24 in Study of Pegasys + Ribavirin Compared to Standard Interferon + Ribavirin - Nov 19, 2001
- More on the HALT-C Trial: 4-year study of Maintenance Therapy in 1350 patients Written for NATAP by Mark Sulkowski, MD, Johns Hopkins University School of Medicine (AASLD) Dallas, Texas - Nov 19, 2001
- Pegylated interferon alfa/ribavirin in persons who failed to prior interferon based therapy Written for NATAP by Mark Sulkowski, MD, Johns Hopkins University School of Medicine (AASLD) Dallas, Texas - Nov 19, 2001
- Hepatitis B Therapy at AASLD Written for NATAP by Douglas T. Dieterich, MD Cabrini Hospital and NYU Medical Center, NYC - Nov 19, 2001
- How Often Should You Do a Liver Biopsy? - Nov 18, 2001
- New Hepatitis B Drugs - Nov 16, 2001
- HIV/HCV Coinfection; Hispanics & HCV; Cognitive Impairment - Nov 16, 2001
- Interferon Improves Risk for Death and Cancer; New Ribavirin in Early Development; Normal ALT in African-Americans; Fats, Overweight, Diabetes in HCV; How Often Should You Do a Biopsy in HCV/HIV Coinfection - Nov 13, 2001
- HCV Viral Load Ultrasensitive Testing - Nov 13, 2001
- Brief Highlights From Day 1 at AASLD, Poster Session: HCV Therapy 1 - Nov 13, 2001
- HCV Therapy in HCV/HIV Coinfection - Nov 13, 2001
- OPEN-LABEL PHASE 1B STUDY OF HEPATITIS C VIRAL DYNAMICS WITH OMEGA INTERFERON TREATMENT - Nov 12, 2001
- HCV Therapy Adherence; New drugs - Nov 12, 2001
- Care Services for HCV/HIV Coinfected - Nov 9, 2001
- Early week 24 African-Americans Response to Pegasys + Ribavirin - Nov 9, 2001
- EFFECT OF INTERFERON THERAPY ON THE RISK OF HEPATOCELLULAR CARCINOMA AND MORTALITY IN PATIENTS WITH CHRONIC HEPATITIS C: A LARGE RETROSPECTIVE COHORT STUDY OF 3296 PATIENTS - Nov 9, 2001
- Preliminary Notes From Dallas AASLD Liver/hepatitis Conference: - Nov 5, 2001
|
|
| |
|
|
|
|
|
